Dermapharm Holding SE (DMPHF)
47.69
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
Dermapharm Net Income (Quarterly) : 26.92M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.92M |
| March 31, 2026 | 52.79M |
| December 31, 2025 | 42.08M |
| September 30, 2025 | 48.04M |
| June 30, 2025 | 23.68M |
| March 31, 2025 | 34.94M |
| December 31, 2024 | 20.32M |
| September 30, 2024 | 36.00M |
| June 30, 2024 | 18.13M |
| March 31, 2024 | 46.75M |
| December 31, 2023 | -3.619M |
| September 30, 2023 | 26.41M |
| June 30, 2023 | -10.32M |
| March 31, 2023 | 52.68M |
| December 31, 2022 | 29.69M |
| September 30, 2022 | 52.26M |
| June 30, 2022 | 15.39M |
| March 31, 2022 | 41.66M |
| December 31, 2021 | 81.63M |
| Date | Value |
|---|---|
| September 30, 2021 | 72.71M |
| June 30, 2021 | 47.68M |
| March 31, 2021 | 43.66M |
| December 31, 2020 | 28.95M |
| September 30, 2020 | 26.38M |
| June 30, 2020 | 13.50M |
| March 31, 2020 | 29.54M |
| December 31, 2019 | 21.14M |
| September 30, 2019 | 21.49M |
| June 30, 2019 | 22.66M |
| March 31, 2019 | 21.83M |
| December 31, 2018 | 17.22M |
| September 30, 2018 | 25.76M |
| June 30, 2018 | 19.77M |
| March 31, 2018 | 26.28M |
| December 31, 2017 | 17.53M |
| September 30, 2017 | 27.41M |
| June 30, 2017 | 21.18M |
| March 31, 2017 | 21.62M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| AstraZeneca PLC | 3.076B |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Avadel Pharmaceuticals Plc | 0.02M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 331.55M |
| Total Expenses (Quarterly) | 304.55M |
| EPS Diluted (Quarterly) | 0.5451 |
| Enterprise Value | 3.471B |
| Gross Profit Margin (Quarterly) | 33.36% |
| Profit Margin (Quarterly) | 8.12% |
| Earnings Yield | 6.75% |
| Operating Earnings Yield | 12.15% |
| Normalized Earnings Yield | 7.912 |